Agilent Technologies Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Agilent Technologies Inc (A) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Agilent Technologies Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 7,372M vs 257,498M combined for tracked competitors (2.8% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (+1.9% annualized vs trailing 12 months), vs accelerating (+8.0%) for its tracked peer group.
- Growth: Agilent Technologies Inc generated 8.1% revenue growth year over year in Q3 2026, vs 13.3% for its tracked competitors combined.
- Profitability: Its 19.3% net margin compares with 25.7% for the peer group.
- Scale: Agilent Technologies Inc ranks #1 of 32 companies by market capitalization in the Laboratory Analytical Instruments industry, holding 21.7% of industry market cap.
- Peer revenue share: Agilent Technologies Inc accounted for 2.6% of combined revenue among its tracked peer group, down from 2.8% a year earlier.
- Peer differentiation: Revenue per employee of $0.41M compares with $0.80M for the peer group (0.5x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
A Sales vs. its Competitors, Q3 2026
Agilent Technologies Inc reported revenue growth of 8.06 % year on year in Q3 2026, below its competitors' combined revenue growth of 13.29 %.
With a net margin of 19.28 %, Agilent Technologies Inc reported lower profitability than its competitors (25.69 %).
Agilent Technologies Inc generated 2.63 % of the combined sales of its peer group, down from 2.75 % a year earlier.
Agilent Technologies Inc vs. its Competitors, Q3 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Agilent Technologies Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Agilent Technologies inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (15) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Agilent Technologies Inc's competitor groups requires a Commercial License.
For context: the Laboratory Analytical Instruments industry grew revenue 13.3% year over year, combined, vs 8.1% for Agilent Technologies Inc. Agilent Technologies Inc's share of combined industry revenue moved from 18.22% to 17.38%, a loss of 0.84 percentage points.
Agilent Technologies Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Agilent Technologies inc | Yes | Yes | Yes | No |
| Competitors combined (67) | ||||
| High-Confidence Competitors (19) | ||||
| Similar-Size Competitors (5) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 87.50 % (7 of 8) | 37.50 % (3 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
A Stock Performance relative to its Competitors
A Stock Performance relative to High-Confidence Competitors
A Stock Performance relative to Similar-Size Competitors
A Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | 10x Genomics Inc | 282.9% | Outperformed |
| 2 | Twist Bioscience Corporation | 282.9% | Outperformed |
| 3 | Ase Technology Holding Co Ltd | 282.9% | Outperformed |
| 4 | Skywater Technology Inc | 282.9% | Outperformed |
| 5 | Formfactor inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Agilent Technologies Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Agilent Technologies Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Agilent Technologies inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Agilent Technologies inc | 49,584.43 | 7,372.00 |
| Taiwan Semiconductor Manufacturing Company Limited | 2,348,690.03 | 121,423.20 |
| Asml Holding Nv | 688,901.35 | 36,586.96 |
| Lam Research Corporation | 396,578.75 | 23,232.69 |
| Applied Materials Inc | 389,408.00 | 30,837.00 |
| Thermo Fisher Scientific Inc | 251,760.60 | 46,336.00 |
| SUBTOTAL | 5,474,977.67 | 724,026.27 |
Sign in to see all competitors of Agilent Technologies inc .
Sources: Agilent Technologies inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Agilent Technologies inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Agilent Technologies Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Volitionrx Limited | Named by the company | 85% |
| Illumina, Inc. | Named by the company | 85% |
| Twist Bioscience Corporation | Named by the company | 85% |
| Cytek Biosciences Inc | Named by the company | 85% |
| Abbott Laboratories | Named by the company | 85% |
| Waters Corporation | Named by the company | 85% |
| Danaher Corporation | Named by the company | 85% |
| Revvity, Inc. | Named by the company | 85% |
| Thermo Fisher Scientific Inc. | Named by the company | 85% |
| Nautilus Biotechnology Inc | Named by the company | 85% |
| AB Sciex | Named by the company | 85% |
| Roche Group | Named by the company | 85% |
| Guardant Health Inc | Named by the company | 85% |
| Bio techne Corp | Named by the company | 85% |
| Bruker, Inc. | Named by the company | 85% |
| PerkinElmer Inc. | Named by the company | 85% |
| Shimadzu Corporation | Named by the company | 85% |
| Quantum si Incorporated | Named by the company | 85% |
| Affymetrix, Inc. | Named by the company | 85% |
| Leica Biosystems, Inc. | Named by the company | 85% |
| Roche Ventana Medical Systems, Inc. | Named by the company | 85% |
| 908 Devices inc | Named by the company | 85% |
| Sophia Genetics Sa | Named by the company | 85% |
| Avecia | Named by the company | 85% |
| Nitto Denko | Named by the company | 85% |
| Sartorius | Named by the company | 85% |
| Alcon inc | Named by the company | 85% |
| Teradyne Inc | Named by the company | 85% |
| Flir Systems Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Agilent Technologies Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Agilent Technologies Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Agilent Technologies inc | Agilent CrossLab 41.36 % |
| Lam Research Corporation | Reportable 100.00 % |
| Applied Materials Inc | Semiconductor Systems 75.41 % |
| Thermo Fisher Scientific Inc | Clinical Research 19.98 % |
| Kla Corporation | Semiconductor Process Control 90.30 % |
| Abbott Laboratories | Diabetes Care 17.78 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Agilent Technologies inc .
Agilent Technologies Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Agilent Technologies inc | 49,584 | 407,293 | 79,558 |
| Taiwan Semiconductor Manufacturing Company Limited | 2,348,690 | 1,713,299 | 762,463 |
| Asml Holding Nv | 688,901 | 827,591 | 243,447 |
| Lam Research Corporation | 396,579 | 997,111 | 311,820 |
| Applied Materials Inc | 389,408 | 844,849 | 253,890 |
| Thermo Fisher Scientific Inc | 251,761 | 370,688 | 55,912 |
| PEERS TOTAL | 5,425,393 | 799,029 | 137,280 |
Sign in to see all peers for Agilent Technologies inc .
Agilent Technologies Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Agilent Technologies inc | Americas 41.63 % |
| Asml Holding Nv | Rest of Europe and Middle East 1.43 % |
| Lam Research Corporation | China 33.83 % |
| Applied Materials Inc | Taiwan 27.24 % |
| Thermo Fisher Scientific Inc | North America 51.27 % |
| Kla Corporation | Taiwan 25.45 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Agilent Technologies inc .
Agilent Technologies Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 28 companies in Agilent Technologies Inc's industry classification, broader than the peer set above. Market cap in millions of $.Agilent Technologies Inc ranks #1 of 28 companies by market capitalization in its industry, holding 21.70 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,474, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Agilent Technologies inc | 48,959 | 21.70 % |
| 2 | Waters Corporation | 42,302 | 18.75 % |
| 3 | Illumina Inc | 40,831 | 18.10 % |
| 4 | Mettler toledo International Inc | 30,472 | 13.51 % |
| 5 | Revvity Inc | 1,234 | 5.2% |
| 6 | 10x Genomics Inc | 1,234 | 5.2% |
| 7 | Avantor Inc | 1,234 | 5.2% |
| 8 | Bio rad Laboratories Inc | 1,234 | 5.2% |
| 9 | Bruker Corporation | 1,234 | 5.2% |
| 10 | Alamar Biosciences Inc | 1,234 | 5.2% |
Market cap and industry share for the rest of Agilent Technologies Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-28.
Agilent Technologies Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 1 | Agilent Technologies inc | 48,959 | 41.93 % |
| 2 | Waters Corporation | 42,302 | 49.68 % |
| 3 | Illumina Inc | 1,234 | 12.3% |
| 4 | Mettler toledo International Inc | 1,234 | 12.3% |
| 5 | Revvity Inc | 1,234 | 12.3% |
| 6 | 10x Genomics Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Agilent Technologies Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Agilent Technologies Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Laboratory Analytical Instruments industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (45 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 53.83 % | 40.40 % (avg) | +13.4 pp |
| Operating Margin | 22.23 % | industry median | +35.4 pp |
| EBITDA Margin | 32.19 % | -18.51 % (avg) | +50.7 pp |
| Capital Intensity (Capex / Revenue) | 4.64 % | 3.93 % (avg) | +0.7 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Agilent Technologies Inc's Valuation vs Competitive Position
Valuation multiples vs the Laboratory Analytical Instruments industry average (45 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 25.2x | 34.1x | -8.9x |
| EV / EBITDA | 16.0x | 22.1x | -6.1x |
| P/B | 5.2x | 2.6x | +2.5x |
| Return on Equity | 20.60 % | industry aggregate | 11.82 % |
| Return on Invested Capital | 9.20 % | -11.56 % (avg) | 20.76 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Agilent Technologies Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 8.84 % | 8.04 % | 4.99 % | 5.61 % | 16.55 % | 7.53 % | -3.21 % | 8.38 % |
| Operating Margin | 18.93 % | 18.73 % | 17.30 % | 17.34 % | 21.64 % | 24.07 % | 26.55 % | 20.61 % |
| Return on Invested Capital | 7.48 % | 7.66 % | 7.34 % | 7.48 % | 10.06 % | 11.91 % | 11.29 % | 8.66 % |
| P/E | 117.0x | 19.5x | 34.3x | 45.0x | 38.6x | 33.9x | 32.0x | 31.7x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Agilent Technologies Inc's Strategic Group Map
Every company in Agilent Technologies Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Agilent Technologies Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Agilent Technologies Inc's BCG Growth-Share Matrix
Relative market share (vs Agilent Technologies Inc's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Agilent Technologies Inc falls in the Cash Cow quadrant: relative market share of 1.16x vs its largest competitor, in an industry growing revenue 4.6% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Agilent Technologies Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 1,474 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 4.64 % vs industry average 3.93 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Agilent Technologies Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Agilent Technologies Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Agilent Technologies Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Agilent Technologies Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Agilent Technologies Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Market leader by capitalization in its industry (#1 of 28, 21.70 % share).
- Operating margin 35.4 points above the industry median.
- Return on equity 11.8 points above the industry aggregate.
- Outperforming the U.S.A. 500 over the trailing 12 months.
Weaknesses
No rule matched.
Opportunities
- Trades at a lower P/E than the industry average (25.2x vs 34.1x) despite a higher return on invested capital -- a possible re-rating opportunity.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Agilent Technologies Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Agilent Technologies inc | 0.77 | 2.02 | 1.02 |
| Taiwan Semiconductor Manufacturing Company Limited | 1.82 | 2.51 | 0.02 |
| Asml Holding Nv | - | 1.26 | 0.22 |
| Lam Research Corporation | 0.96 | 2.38 | 0.38 |
| Applied Materials Inc | 0.79 | 2.53 | 0.29 |
| Thermo Fisher Scientific Inc | 0.32 | 1.62 | 0.78 |
Sign in to see all peers for Agilent Technologies inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Agilent Technologies Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Agilent Technologies inc | Q2 2026 | +8.1 % | +7.7 % |
| Taiwan Semiconductor Manufacturing Company Limited | Q4 2025 | +37.6 % | +53.1 % |
| Asml Holding Nv | Q4 2025 | +15.6 % | +26.9 % |
| Lam Research Corporation | Q2 2026 | +30.0 % | +32.4 % |
| Applied Materials Inc | Q2 2026 | +24.8 % | +42.7 % |
| Thermo Fisher Scientific Inc | Q2 2026 | +10.5 % | +7.6 % |
| PEERS TOTAL | +19.1 % | +51.2 % |
Sign in to see all peers for Agilent Technologies inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Agilent Technologies Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Agilent Technologies inc | Q2 2026 | -1.6 % | -22.3 % |
| Taiwan Semiconductor Manufacturing Company Limited | Q4 2025 | +25.7 % | +39.1 % |
| Asml Holding Nv | Q4 2025 | +11.9 % | -21.7 % |
| Lam Research Corporation | Q2 2026 | +25.6 % | +9.6 % |
| Applied Materials Inc | Q2 2026 | +21.1 % | +21.1 % |
| Thermo Fisher Scientific Inc | Q2 2026 | +142.5 % | +53.1 % |
Sign in to see all peers for Agilent Technologies inc .
Agilent Technologies Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Agilent Technologies inc | 10.97% | 19.84% | 41.99% |
| Taiwan Semiconductor Manufacturing Company Limited | 21.37% | 26.29% | 31.41% |
| Asml Holding Nv | 19.00% | 36.53% | 49.00% |
| Lam Research Corporation | 33.19% | 41.27% | 67.41% |
| Applied Materials Inc | 23.70% | 28.79% | 41.02% |
| Thermo Fisher Scientific Inc | 6.36% | 7.71% | 13.37% |
Sign in to see all peers for Agilent Technologies inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Agilent Technologies Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Agilent Technologies inc | 34.56 | 6.73 |
| Taiwan Semiconductor Manufacturing Company Limited | 84.65 | 19.34 |
| Asml Holding Nv | 71.69 | 18.83 |
| Lam Research Corporation | 54.60 | 17.07 |
| Applied Materials Inc | 42.07 | 12.63 |
| Thermo Fisher Scientific Inc | 36.52 | 5.43 |
| PEERS AVERAGE | 43.95 | 7.56 |
Sign in to see all peers for Agilent Technologies inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.